Medical Director - Oncology Clinical Development

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade.

Responsibilities include:

• Demonstrating ability to incorporate global considerations into decision making.
• Ensuring high-quality protocol development aligned with the Clinical Development Plan to effectively determine a medicine’s potential efficacy, safety profile, key areas of product differentiation and value to patient in the shortest possible timeframe.
• Assuming medical responsibility for clinical trials with active participation in real-time medical monitoring, including patient eligibility assessment, study design questions, and addressing urgent safety questions.
• Overseeing blinded review of data packages intended for IDMCs.
• Reviewing/monitoring safety data in collaboration with the pharmacovigilance group for active clinical studies.
• Interpreting and summarising study results consistent with objectives to define safety, efficacy, pharmacokinetic/pharmacodynamic, and patient-reported outcomes.
• Participating in the authoring of clinical study reports and regulatory documents and collaborating with colleagues in Regulatory Affairs, CMC, Toxicology, Research, and Pharmacology to respond to health authority and ethics committee queries.
• Collaborating with Principal Investigators in the authoring of publications associated with clinical data.
• Networking extensively to develop long-term strategic partnerships with thought leaders both internally and externally, in support of GSK’s vision.
• Serving as a core member of the Clinical Matrix Team for one or more assets in development.
• Participating in Oncology Clinical Development-wide initiatives and workstreams as appropriate.

Basic Qualifications:

• Medical degree with board certification/eligibility or registration qualifications in medical oncology, hematology or hematology/oncology.
• Experience in the pharmaceutical/biotechnology industry, clinical academic medicine, or clinical medical practice, in the field of hematology and/or oncology.
• Oncology clinical drug development experience in the conduct of clinical trials and their subsequent publications.

Preferred Qualifications:

• MD / PhD preferred.
• Clinical experience of managing patients with hematological malignancies.
• Oncology clinical research and drug development experience focused on hematological malignancies, including multiple myeloma.
• Sound understanding of biological mechanisms, clinical strategy, scientific interpretation of disease and target-based literature.
• Robust knowledge of disease-specific research priorities, public health needs, competitor landscape, clinical practice trends, and treatment guidelines evolution.

If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges from $222,750 to $371,250. The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share-based long-term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.

The annual base salary in Poland for new hires in this position ranges from PLN 455,250 to PLN 758,750 gross, taking into account a number of factors including the candidate’s skills, experience, education level and the market rate for the role. Depending on the role and internal policies, the position may also be eligible for a bonus and/or awards for exceptional performance. All statutory benefits will be maintained in accordance with Polish law. Other benefits may also be offered, which may include private healthcare, additional paid days off, life insurance, private pension plan and fully paid parental leave.